The news roundup for the week ending 18 March 2016.
Big deal: Aprea records $51m series B
Biotechnology spinout Aprea has secured the largest funding round of any Karolinska Development portfolio company to date.
Cambridge Epigenetix advances funding sequence with $21m
GV led the genome sequencing spinout’s series B round, which followed a $5.5m series A in late 2014.
StartX helps series A funding flow for Arterys
Arterys, the developer of a medical imaging platform for blood flow, has completed a $12m round that included Stanford’s StartX Fund.
Prenetics thinks about $10m series A
Ping An has contributed to a series A round for Prenetics, which develops DNA testing technology to help deliver more accurate diagnoses.
Microsure is certain about spinning out
Microsure has been spun out by Eindhoven and Maastricht following an STW Take-Off grant gained in January 2016.
Autolus fights cancer with $57m series B
University College London cancer treatment spinout Autolus licences additional technology from the university as it raises $57m in its series B round.
Illinois boosts spinout retention
An increasing number of university spinouts and startups founded in Illinois keep their offices in the state.
Capella sings about $15.8m series A
Osage University Partners backs a $15.8m investment for antibody discovery company Capella Bioscience.
Silicon Microgravity attracts Cambridge
University of Cambridge Enterprise Fund III has invested an undisclosed sum in its spinout.
